+447480022765Editorial P:1-3
Draft National Health Policy of India and Determining Cost-effectiveness Threshold
Prashant Sakharkar
Editorial P:122-123
Adverse drug reactions in the era of multi-morbidity and polypharmacy
T Javier Birriel, Reina Uchino, Noran Barry, Tracy Butryn, Donna M Sabol, Pamela L Valenza, Stanislaw P Stawicki
Editorial P:44
Prescribing pattern of interns: Time for new interventions
Kieran Walsh
Editorial P:87-88
Qualitative research method-interviewing and observation
Shazia Jamshed
Editorial P:56
Why angiotensin converting enzyme inhibitors and angiotensin II receptor blockers are not prescribed in the management of hypertension among hemodialysis patients in India
Uday Venkat Mateti, Anantha Naik Nagappa, Rajesh Balkrishnan
Editorial P:24-26
A survey on medicines safety and usage in community pharmacy
Varsha A Prabhu, Vaishnavi Naik, Sahiti Doddapaneni, Uday Venkat Mateti, Anantha Naik Nagappa
Editorial P:76-77
The examination of geriatric pharmacotherapy
Abimbola Farinde
Editorial P:93-94
Bipolar disorder: A brief examination of lithium therapy
Abimbola Farinde
Editorial P:49-50
Brief examination of psychopharmacology
Abimbola Farinde
Editorial P:330-331
Increasing the effi ciency of detecting active tuberculosis cases in intermediate and high-burden tuberculosis countries: A way forward
Muhammad Atif, Syed Azhar Syed Sulaiman